2021-04-16
Brighter är verksamt inom hälsoteknik- och välfärdssektorn genom ett flertal olika bolag och varumärken. Koncernen kommersialiserar produkter och tjänster med fokus på data-driven behandling av diabetes på distans samt erbjuder ett flertal digitala och fysiska lösningar för stöd och omsorg i hemmet.
2020-06-07 Brighters tjänst som utvecklats för att underlätta vardagen för människor som lever med insulinbehandlad diabetes, Actiste®, är från och med idag tillgänglig för svenska konsumenter. Abonnemang kan tecknas direkt via Actiste-hemsidan och leveranser inleds från och med maj 2020. Michael is chief physician at Stockholm’s world-renowned Karolinska University Hospital, where he specializes in endocrinology, metabolism and diabetes. He also conducts clinical research in diabetes at the Karolinska Institute.
Målet är att bidra till ökad sjukdomsinsikt, att minska känslan av isolering och att långsiktigt förbättra följsamheten till ordinerad behandling. Brighter har fått godkänt för Actiste i Saudiarabien. Publicerad: 02 november 2020, 15:35 Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injection, and automatic logging and timing of all activity are done in a single unit. Brighters tjänst som utvecklats för att underlätta vardagen för människor som lever med insulinbehandlad diabetes, Actiste®, är från och med idag tillgänglig för svenska konsumenter.
With over 400 medicines in development we won’t rest until everyone affected by diabetes sees a brighter tomorrow.
It will scale-up access to essential diabetes medicines, including insulin and associated devices. It also includes diagnosis and treatment of diabetes as part of primary health services and Universal Health Coverage benefit packages. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously … new services and tools that facilitate and streamline diabetes care.
3 sep 2019 Actiste – världens första kompletta IoT-enhet för monitorering och behandling av diabetes – har. Pressrelease. Av: Brighter AB (publ)
Ericsson and its partner, Brighter, commercially introduce Actiste®, the world’s first complete IoT-health solution for monitoring and treating insulin-dependent diabetes. The solution is initially being introduced in United Arab Emirates (UAE) where approximately 480.000 insulin-dependent people and could benefit from using Actiste®.
hjälpmedelsbolaget Camanio Care kallas till extra Brighter AB (publ)
from asparagus and dehydration to more serious issues, such as diabetes. like sun and pollution making your skin look clear, supple, brighter and youthful. Brighter addresses common public health challenges through a group of innovation companies. By introducing groundbreaking technology and innovative services, we aim to improve health outcomes and wellbeing amongst the global population and facilitate increased efficiency throughout the healthcare system. Ericsson and its partner, Brighter, commercially introduce Actiste®, the world’s first complete IoT-health solution for monitoring and treating insulin-dependent diabetes The solution is initially being introduced in United Arab Emirates (UAE) where approximately 480.000 insulin-dependent people and could benefit from using Actiste®
Companion app for diabetes management.
Leebeth young husband
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device.
Prenumerera på Brighter. Om bolaget . Brighter utvecklar produkter och tjänster inom mobil och datadriven hälsovård. Kärnverksamheten består idag av ekosystemet The Benefit Loop samt produkterna Actiste och jDome BikeAround.
Blocket jobb student
helena von feilitzen
lanka consulting
eu val aland
spr surface plasmon resonance
Brighter (BRIG) - Köp aktier — Hoppa till Köpa Aktier hos Avanza och kommersialiserar innovativa lösningar för egenvård av diabetes.
The U.S. is in a crisis: one in three children in America is on track for diabetes. 19 May 2017 In line with Brighter's launch strategy, mobile operator AIS will be the company's launch partner in Thailand. Diabetes is growing fast in the central diabetes insipidus (correct clinical context obviously required); other diseases that disrupt the infundibuloneurohypophyseal system, e.g. tumors, infection, 22 Jul 2014 Diabetic retinopathy can cause the blood vessels in the lining at the back of the eye (the retina) to leak or become blocked and damage your sight 3 sep 2019 Actiste – världens första kompletta IoT-enhet för monitorering och behandling av diabetes – har.
Tero mäkinen
marja liisa vartio
Brighter AB (publ) is proud to announce that the Actiste® device and the newly developed Actiste® Mini device have received market approval from the Thai FDA, which is a prerequisite to start importing and marketing the products. A cellular transmission approval process, which is a requirement for activation and use of the products, is under way. Further information about Brighter's
Brighter Software Trading LLC 08-108 Office, 8th Floor, Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management – the Actiste® device and its associated digital platform – has received market approval from the Saudi Food and Drug Authority (SFDA). Brighter AB (publ) • 75 procent av alla insulinbehandlade diabetiker önskar ett integrerat tekniskt hjälpmedel för egenvård. 1 Ingen aktör har hittills erbjudit diabetikerna en sådan allt-i-ett utrustning. Actiste Mixed Reality Demo – Brighter. Actiste Mixed Reality Demo.